About
Mission
Connection to Lupus Research Alliance
Leadership & Board
Contact Lupus Therapeutics
Patient & Community Engagement
Patient Advisory Boards
Patient Protocol Review Council
Peer-to-Peer Education
Community-Based Health Equity Initiatives
Clinical Care & Clinical Trials
Lupus Therapeutics Healthcare Provider Directory™
Clinical Trials
Phases of Clinical Development
Clinical Research Partners
Current Collaborations and Initiatives
Advisory & Consulting Services
Clinical Research Services
LuCIN
Newsroom
NEWSROOM
Press Releases
In the News
Logo & Resources Library
Recent News
News Update
Lupus Has Nerve Shows Large International Study
January 6, 2020
New research published in Arthritis and Rheumatology shows that peripheral nervous system (PNS) disease is an important part of...
News Update
Great News for Lupus Nephritis Treatment: Itolizumab Fast-Tracked by FDA
December 10, 2019
The Lupus Research Alliance (LRA) is pleased to share that a potential new treatment in development by Equillium, Inc....
News Update
Breadth of Clinical Research Presented at the 2019 ACR/ARP Annual Meeting Brings Hope for New Lupus Treatments
November 14, 2019
The Lupus Research Alliance staff was on the ground at the 2019 ACR/ARP Annual Meeting and highly encouraged by...
News Update
Potential New Treatment in Phase III Trial
October 16, 2019
The Lupus Research Alliance is excited to announce that a potential new medicine for lupus—anifrolumab—reduced disease activity versus placebo...
News Update
Welcoming Daniel J. Wallace, MD to Lupus Therapeutics
October 16, 2019
The Lupus Research Alliance (LRA) affiliate Lupus Therapeutics is pleased to announce that Daniel J. Wallace, MD joins as...
News Update
Peer-to-Peer Involvement Advances Scientific Exploration
October 16, 2019
Many dynamics of lupus contribute to the fact that its complexities have eluded the scientific community—but new hope may...
News Update
Lupus Therapeutics Shifting the Paradigm
October 16, 2019
The Lupus Research Alliance (LRA)—going bold and thinking big—has once again shifted the status quo of lupus research by...
News Update
10 Lupus Therapeutics Studies Currently Underway
October 6, 2019
TAK-079A Study to Evaluate the Safety of TAK-079 PAISLEY-SLEA Phase II study to evaluate a novel, oral therapy in SLE ORKIDSA...
Press Release
Dr. Daniel Wallace Appointed to Lupus Therapeutics Board
July 18, 2019
The Lupus Research Alliance (LRA) affiliate Lupus Therapeutics is pleased to announce that Daniel Wallace, MD joins as a...
Press Release
Lupus Therapeutics Expands Collaboration with Bristol-Myers Squibb to Test Potential Treatment for Lupus
June 27, 2019
The Lupus Research Alliance (LRA) and its affiliate, Lupus Therapeutics, announced that it has broadened its collaboration with Bristol-Myers...
News Update
Lupus Research Alliance and Lupus Therapeutics – Leading Voices in Trial Diversity
June 25, 2019
Caroline Donovan, Manager of Patient Engagement at Lupus Research Alliance (LRA) affiliate Lupus Therapeutics (LT) took part in a...
Press Release
VALUE Study Results Reported at EULAR
June 13, 2019
Results of the first clinical trial sponsored by the Lupus Research Alliance and conducted through its Lupus Clinical Investigators...
Posts pagination
◀︎
1
2
3
4
5
▶︎